Marie Jauffret-Roustide

Verified @inserm.fr

Centre d'étude des mouvements sociaux (Inserm U1276/CNRS UMR 8044/EHESS)
Inserm

RESEARCH, TEACHING, or OTHER INTERESTS

Social Sciences, Sociology and Political Science, Public Health, Environmental and Occupational Health, Multidisciplinary
4129

Scholar Citations

35

Scholar h-index

100

Scholar i10-index

RECENT SCHOLAR PUBLICATIONS

  • Legacies of prohibition in Canada: calling for a reproductive justice approach to cannabis use during pregnancy
    R Chabot, K Alunni-Menichini, KA Dominguez-Cancino, K Bertrand, ...
    Cogent Social Sciences 12 (1), 2667551 , 2026
    2026
  • “It Shouldn’t Become the Club Med of Drug Problems Here”: Navigating Community Responses to Harm Reduction Services in Four Belgian Cities
    C De Ruysscher, S André, A Pouille, W Vanderplasschen, ...
    Contemporary Drug Problems, 00914509261452957 , 2026
    2026
  • Resisting in a land of drug trafficking
    A Kessaci, M Jauffret-Roustide
    ESPRIT, 41-49 , 2026
    2026
  • Living with Crack: An Interview with Carole Eugenie Melissa
    JM Granier, M Jauffret-Roustide
    ESPRIT, 99-102 , 2026
    2026
  • The Portuguese Model of Drug Decriminalization
    R Fuertes, M Jauffret-Roustide
    ESPRIT, 37-75 , 2026
    2026
  • Alcov2: a National Questionnaire Survey for Understanding the Transmission of SARS-CoV-2 in French Households during First Lockdown
    A Lambert, A Bonnet, P Clavier, P Biousse, L Clavières, S Brouillet, ...
    medRxiv, 2026.02. 23.26344954 , 2026
    2026
  • El impacto del narcotráfico en el Estado de derecho
    J Durain, É Blanc, JM Granier, M Jauffret-Roustide
    Esprit, 51-59 , 2026
    2026
  • El modelo portugués de despenalización de las drogas
    R Fuertes, M Jauffret-Roustide
    Esprit, 67-75 , 2026
    2026
  • Ce que fait le narcotrafic à l’État de droit
    J Durain, É Blanc, JM Granier, M Jauffret-Roustide
    Esprit, 51-59 , 2026
    2026
  • Le modèle portugais de décriminalisation des drogues
    R Fuertes, M Jauffret-Roustide
    Esprit, 67-75 , 2026
    2026
  • Résister en terre de narcotrafic
    A Kessaci, M Jauffret-Roustide
    Esprit, 41-49 , 2026
    2026
  • Vivre le crack
    CE Melissa, JM Granier, M Jauffret-Roustide
    Esprit, 99-102 , 2026
    2026
  • Drogues, qualités et morale. Les stratégies d’évitement du risque, de préservation de soi et de contournement de la stigmatisation: expériences, situations et discours
    M Jauffret-Roustide
    Médecine et Philosophie 14 (1), 73-82 , 2026
    2026
  • Violence in harm reduction: Exploring the social, political, and emotional conditions of harm reduction work
    G Dumont, M Jauffret‐Roustide
    Medical Anthropology Quarterly, e70055 , 2025
    2025
  • Global cannabis cultivation as a gendered activity: Findings from the 2020 International Cannabis Cultivation Questionnaire
    JS Meisel, JE Brummer, TF Søgaard, GR Potter, J Grigg, ...
    International Journal of Drug Policy 146, 105039 , 2025
    2025
    Citations: 2
  • Integrative exploration of bio-psycho-social determinants of DSM-5 severity levels of opioid use disorder: the BEBOP cohort study protocol
    L Lalanne, PE Lutz, A Caparros-Roissard, E Ruppert, G Waeckerle, ...
    BMJ open 15 (10), e093358 , 2025
    2025
  • Reprint of: Monitoring HIV, HCV and HBV among people who use drugs in France. A reflective feed-back on a 25-year experiment based on mixed methods. The ANRS-Coquelicot survey
    M Jauffret-Roustide
    International Journal of Drug Policy 144, 104727 , 2025
    2025
  • Impact of the COVID-19 pandemic on cannabis cultivation and use in 18 countries
    B Werse, G Kamphausen, TF Søgaard, D Bear, M Audran, C Wilkins, ...
    International Journal of Drug Policy 144, 104652 , 2025
    2025
    Citations: 1
  • Global patterns in small-scale cannabis growers’ distribution practices: Exploring the grower-distributor nexus
    TF Søgaard, JE Brummer, C Wilkins, SR Sznitman, EL Sevigny, VA Frank, ...
    International Journal of Drug Policy 144, 104463 , 2025
    2025
    Citations: 10
  • Conflict and social control among cannabis growers
    EL Sevigny, G Potter, C Wilkins, MJ Barratt, TF Søgaard, P Hakkarainen, ...
    International Journal of Drug Policy 144, 104292 , 2025
    2025
    Citations: 2

MOST CITED SCHOLAR PUBLICATIONS

  • Une épidémie politique. La lutte contre le sida en France (1981-1996)
    P Pinell, C Broqua, de Busscher Pierre-Olivier, M Jauffret, C Thiaudière
    Presses universitaires de France , 2002
    2002
    Citations: 222
  • Model projections on the impact of HCV treatment in the prevention of HCV transmission among people who inject drugs in Europe
    H Fraser, NK Martin, H Brummer-Korvenkontio, P Carrieri, O Dalgard, ...
    Journal of hepatology 68 (3), 402-411 , 2018
    2018
    Citations: 182
  • A national cross-sectional study among drug-users in France: epidemiology of HCV and highlight on practical and statistical aspects of the design
    M Jauffret-Roustide, Y Le Strat, E Couturier, D Thierry, M Rondy, ...
    BMC Infectious Diseases 9 (1), 113 , 2009
    2009
    Citations: 122
  • Hepatitis C treatment as prevention of viral transmission and liver‐related morbidity in persons who inject drugs
    A Cousien, VC Tran, S Deuffic‐Burban, M Jauffret‐Roustide, JS Dhersin, ...
    Hepatology 63 (4), 1090-1101 , 2016
    2016
    Citations: 114
  • Prevalence of human immunodeficiency virus and hepatitis C virus among French prison inmates in 2010: a challenge for public health policy
    C Semaille, Y Le Strat, E Chiron, K Chemlal, MA Valantin, P Serre, L Caté, ...
    Eurosurveillance 18 (28) , 2013
    2013
    Citations: 97
  • Estimation de la séroprévalence du VIH et du VHC et profils des usagers de drogues en France, étude InVS-ANRS Coquelicot, 2004
    M Jauffret-Roustide, E Couturier, Y Le Strat, F Barin, J Emmanuelli, ...
    Bull Epidémiol Hebd 33, 244-7 , 2006
    2006
    Citations: 96
  • Mental health of sub-saharan african migrants: The gendered role of migration paths and transnational ties
    J Pannetier, F Lert, MJ Roustide, AD du Loû
    SSM-population health 3, 549-557 , 2017
    2017
    Citations: 91
  • Drug consumption rooms: comparing times, spaces and actors in issues of social acceptability in French public debate
    M Jauffret-Roustide, I Cailbault
    International Journal of Drug Policy 56, 208-217 , 2018
    2018
    Citations: 79
  • Self-support for drug users in the context of harm reduction policy: A lay expertise defined by drug users’ life skills and citizenship
    M Jauffret-Roustide
    Health Sociology Review 18 (2), 159-172 , 2009
    2009
    Citations: 77
  • Prevalence of hepatitis C infection, screening and associated factors among men who have sex with men attending gay venues: a cross-sectional survey (PREVAGAY), France, 2015
    S Vaux, S Chevaliez, L Saboni, C Sauvage, C Sommen, F Barin, ...
    BMC infectious diseases 19 (1), 315 , 2019
    2019
    Citations: 72
  • Hepatitis C virus and HIV seroprevalences, sociodemographic characteristics, behaviors and access to syringes among drug users, a comparison of geographical areas in France …
    L Weill-Barillet, J Pillonel, C Semaille, L Léon, Y Le Strat, X Pascal, ...
    Revue d'epidemiologie et de sante publique 64 (4), 301-312 , 2016
    2016
    Citations: 72
  • Estimation de la séroprévalence du VIH et de l’hépatite C chez les usagers de drogues en France-Premiers résultats de l’enquête ANRS-Coquelicot 2011
    M Jauffret-Roustide, J Pillonel, L Weill-Barillet, L Léon, Y Le Strat, ...
    Bulletin Epidémiologique Hebdomadaire-BEH, 504-509 , 2013
    2013
    Citations: 70
  • Injecting drug use during sex (known as “slamming”) among men who have sex with men: results from a time-location sampling survey conducted in five cities, France
    P Trouiller, A Velter, L Saboni, C Sommen, C Sauvage, S Vaux, F Barin, ...
    International Journal of Drug Policy 79, 102703 , 2020
    2020
    Citations: 69
  • Early cannabis initiation and educational attainment: is the association causal? Data from the French TEMPO study
    M Melchior, C Bolze, E Fombonne, PJ Surkan, L Pryor, ...
    International Journal of Epidemiology 46 (5), 1641-1650 , 2017
    2017
    Citations: 69
  • A socio-structural approach to preventing injection drug use initiation: rationale for the PRIMER study
    D Werb, R Garfein, T Kerr, P Davidson, P Roux, M Jauffret-Roustide, ...
    Harm Reduction Journal 13 (1), 25 , 2016
    2016
    Citations: 67
  • The undiagnosed chronically-infected HCV population in France. Implications for expanded testing recommendations in 2014
    C Brouard, Y Le Strat, C Larsen, M Jauffret-Roustide, F Lot, J Pillonel
    PloS one 10 (5), e0126920 , 2015
    2015
    Citations: 67
  • Design-based inference in time-location sampling
    L Leon, M Jauffret-Roustide, Y Le Strat
    Biostatistics 16 (3), 565-579 , 2015
    2015
    Citations: 64
  • Insufficient access to harm reduction measures in prisons in 5 countries (PRIDE Europe): a shared European public health concern
    L Michel, C Lions, S Van Malderen, J Schiltz, W Vanderplasschen, ...
    BMC public health 15 (1), 1093 , 2015
    2015
    Citations: 63
  • Supervised consumption rooms: the French Paradox
    M Jauffret-Roustide, G Pedrono, N Beltzer
    International Journal of Drug Policy 24 (6), 628-630 , 2013
    2013
    Citations: 63
  • Effectiveness and cost‐effectiveness of interventions targeting harm reduction and chronic hepatitis C cascade of care in people who inject drugs: the case of France
    A Cousien, VC Tran, S Deuffic‐Burban, M Jauffret‐Roustide, G Mabileau, ...
    Journal of Viral Hepatitis 25 (10), 1197-1207 , 2018
    2018
    Citations: 55